<!DOCTYPE html>
<html >

<head>

  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <title>Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정</title>
  <meta name="description" content="Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정">
  <meta name="generator" content="bookdown 0.5.9 and GitBook 2.6.7">

  <meta property="og:title" content="Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정" />
  
  
  

<meta name="author" content="Sungpil Han">


<meta name="date" content="2017-11-28">

  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black">
  
  
<link rel="prev" href="regulation.html">

<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />










<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./index.html">Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> 서론</a></li>
<li class="chapter" data-level="2" data-path="approval.html"><a href="approval.html"><i class="fa fa-check"></i><b>2</b> 모델링과 시뮬레이션을 이용한 특수집단에서 약물 인허가 현황</a><ul>
<li class="chapter" data-level="2.1" data-path="approval.html"><a href="approval.html#-fda---"><i class="fa fa-check"></i><b>2.1</b> 미국 FDA의 인허가에 사용된 예</a><ul>
<li class="chapter" data-level="2.1.1" data-path="approval.html"><a href="approval.html#section-2.1.1"><i class="fa fa-check"></i><b>2.1.1</b> 소아</a></li>
<li class="chapter" data-level="2.1.2" data-path="approval.html"><a href="approval.html#section-2.1.2"><i class="fa fa-check"></i><b>2.1.2</b> 임산부</a></li>
<li class="chapter" data-level="2.1.3" data-path="approval.html"><a href="approval.html#-"><i class="fa fa-check"></i><b>2.1.3</b> 간장애, 신장애</a></li>
</ul></li>
<li class="chapter" data-level="2.2" data-path="approval.html"><a href="approval.html#-emea---"><i class="fa fa-check"></i><b>2.2</b> 유럽 EMEA의 인허가에서 사용된 예</a></li>
<li class="chapter" data-level="2.3" data-path="approval.html"><a href="approval.html#-pmda---"><i class="fa fa-check"></i><b>2.3</b> 일본 PMDA의 인허가에서 사용된 예</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="regulation.html"><a href="regulation.html"><i class="fa fa-check"></i><b>3</b> 모델링과 시뮬레이션 관련 규정</a><ul>
<li class="chapter" data-level="3.1" data-path="regulation.html"><a href="regulation.html#-fda--"><i class="fa fa-check"></i><b>3.1</b> 미국 FDA의 관련 규정</a></li>
<li class="chapter" data-level="3.2" data-path="regulation.html"><a href="regulation.html#-ema--"><i class="fa fa-check"></i><b>3.2</b> 유럽 EMA의 관련 규정</a></li>
<li class="chapter" data-level="3.3" data-path="regulation.html"><a href="regulation.html#-pmda--"><i class="fa fa-check"></i><b>3.3</b> 일본 PMDA의 관련 규정</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="ecb0b8eab3a0ebacb8ed978c.html"><a href="ecb0b8eab3a0ebacb8ed978c.html"><i class="fa fa-check"></i>참고문헌</a></li>
<li class="divider"></li>
<li><a href="https://github.com/asancpt" target="blank">https://github.com/asancpt</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="ecb0b8eab3a0ebacb8ed978c" class="section level1 unnumbered">
<h1>참고문헌</h1>

<div id="refs" class="references">
<div>
<p>EMEA. 2016a. <em>Guideline on the Qualification and Reporting of Physiologically Based Pharmacokinetic (Pbpk) Modelling and Simulation</em>. Vienna, Austria: EMEA. <a href="http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500211315.pdf" class="uri">http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500211315.pdf</a>.</p>
</div>
<div>
<p>———. 2016b. <em>Reflection Paper on Extrapolation of Efficacy and Safety in Paediatric Medicine Development</em>. Vienna, Austria: EMEA. <a href="http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2016/04/WC500204187.pdf" class="uri">http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2016/04/WC500204187.pdf</a>.</p>
</div>
<div>
<p>FDA. 2009. <em>Guidance for Industry End-of-Phase 2a Meetings</em>. Maryland, US: U.S. Department of Health; Human Services Food; Drug Administration. <a href="https://www.fda.gov/downloads/Drugs/.../Guidances/ucm079690.pdf" class="uri">https://www.fda.gov/downloads/Drugs/.../Guidances/ucm079690.pdf</a>.</p>
</div>
<div>
<p>———. 2014. <em>Guidance for Industry: General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products</em>. Maryland, US: U.S. Department of Health; Human Services Food; Drug Administration.</p>
</div>
<div>
<p>ICH. 1993. <em>International Conference on Harmonisation (Ich) Guidance: E7 Studies in Support of Special Populations: Geriatrics</em>. Vienna, Austria: International Conference on Harmonisation.</p>
</div>
<div>
<p>———. 1994. <em>International Conference on Harmonisation (Ich) Guidance: E4 Dose-Response Information to Support Drug Registration</em>. Vienna, Austria: International Conference on Harmonisation.</p>
</div>
<div>
<p>Ke, A B, S C Nallani, P Zhao, A Rostami-Hodjegan, and J D Unadkat. 2012. “A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction.” <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em> 1 (9). Wiley-Blackwell: e3. doi:<a href="https://doi.org/10.1038/psp.2012.2">10.1038/psp.2012.2</a>.</p>
</div>
<div>
<p>Ke, A. B., S. C. Nallani, P. Zhao, A. Rostami-Hodjegan, N. Isoherranen, and J. D. Unadkat. 2013. “A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women.” <em>Drug Metabolism and Disposition</em> 41 (4). American Society for Pharmacology &amp; Experimental Therapeutics (ASPET): 801–13. doi:<a href="https://doi.org/10.1124/dmd.112.050161">10.1124/dmd.112.050161</a>.</p>
</div>
<div>
<p>Leong, R, M L T Vieira, P Zhao, Y Mulugeta, C S Lee, S-M Huang, and G J Burckart. 2012. “Regulatory Experience with Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials.” <em>Clinical Pharmacology &amp; Therapeutics</em> 91 (5). Springer Nature: 926–31. doi:<a href="https://doi.org/10.1038/clpt.2012.19">10.1038/clpt.2012.19</a>.</p>
</div>
<div>
<p>Mehrotra, N., A. Bhattaram, J. C. Earp, J. Florian, K. Krudys, J. E. Lee, J. Y. Lee, et al. 2016. “Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.” <em>Drug Metabolism and Disposition</em> 44 (7). American Society for Pharmacology &amp; Experimental Therapeutics (ASPET): 924–33. doi:<a href="https://doi.org/10.1124/dmd.116.069559">10.1124/dmd.116.069559</a>.</p>
</div>
<div>
<p>Sato, M, Y Ochiai, S Kijima, N Nagai, Y Ando, M Shikano, and Y Nomura. 2017. “Quantitative Modeling and Simulation in PMDA: A Japanese Regulatory Perspective.” <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em> 6 (7). Wiley-Blackwell: 413–15. doi:<a href="https://doi.org/10.1002/psp4.12203">10.1002/psp4.12203</a>.</p>
</div>
<div>
<p>Zhao, Liang. 2016. <em>Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation; Public Workshop</em>. U.S. Department of Health; Human Services Food; Drug Administration. <a href="https://www.fda.gov/downloads/Drugs/NewsEvents/UCM505000.pdf" class="uri">https://www.fda.gov/downloads/Drugs/NewsEvents/UCM505000.pdf</a>.</p>
</div>
<div>
<p>의약품심사부 종양약품과. 2015. <em>약품 개발 시 집단 약동학 활용을 위한 가이드라인</em>. 대한민국: 식품의약품안전평가원. <a href="http://www.nifds.go.kr/nifds/08_part/part03_c_b.jsp?mode=view&amp;article_no=7038&amp;pager.offset=0&amp;board_no=167" class="uri">http://www.nifds.go.kr/nifds/08_part/part03_c_b.jsp?mode=view&amp;article_no=7038&amp;pager.offset=0&amp;board_no=167</a>.</p>
</div>
</div>
</div>






            </section>

          </div>
        </div>
      </div>
<a href="regulation.html" class="navigation navigation-prev navigation-unique" aria-label="Previous page"><i class="fa fa-angle-left"></i></a>

    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": true,
"facebook": false,
"twitter": true,
"google": false,
"weibo": false,
"instapper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/asancpt/ms-special/edit/master/inst/examples/index.Rmd",
"text": "Edit"
},
"download": null,
"toc": {
"collapse": "none"
}
});
});
</script>

</body>

</html>
